右美托咪定作为局部麻醉药辅助剂在球周阻滞中的疗效:一项Meta分析与试验序贯分析
该系统综述与Meta分析纳入16项随机对照试验共1220例成人眼科手术患者,比较单纯局部麻醉药与局部麻醉药联合右美托咪定在球周阻滞中的效果。结果显示右美托咪定可延长感觉和运动阻滞持续时间及首次镇痛需求时间,降低眼内压和补充注射需求,并提高术者满意度。
要点
- 右美托咪定延长运动阻滞持续时间(MD:65.01分钟,P < .001)和感觉阻滞持续时间(MD:81.94分钟,P < .001)。
- 右美托咪定降低眼内压(MD:-2.6 mm Hg,P < .001)并减少补充注射需求(RR:0.44,P = .007)。
- 右美托咪定延长首次镇痛需求时间(MD:97.15分钟,P < .001)并提高术者满意度(RR:1.52,P = .01)。
核心结论
- 与单纯局部麻醉药相比,右美托咪定显著延长感觉和运动阻滞持续时间及首次镇痛需求时间,降低眼内压和补充注射需求,同时提高术者满意度。
研究设计与样本
- 系统综述与Meta分析及试验序贯分析,纳入16项随机对照试验共1220例在球周阻滞下接受眼科手术的成人患者,比较单纯局部麻醉药与局部麻醉药联合右美托咪定。
主要发现
- 与单纯局部麻醉药相比,右美托咪定延长运动阻滞持续时间(MD:65.01分钟,P < .001)和感觉阻滞持续时间(MD:81.94分钟,P < .001)。
- 与单纯局部麻醉药相比,右美托咪定降低眼内压(MD:-2.6 mm Hg,P < .001)并减少补充注射需求(RR:0.44,P = .007)。
- 与单纯局部麻醉药相比,右美托咪定延长首次镇痛需求时间(MD:97.15分钟,P < .001)并提高术者满意度(RR:1.52,P = .01)。
- 敏感性分析和试验序贯分析在所有终点上均一致,大多数终点达到所需信息量,表明合并分析可靠且样本量充足。
关键数值与推荐
- 运动阻滞持续时间:MD 65.01分钟(P < .001),右美托咪定组较单纯局部麻醉药组延长。
- 感觉阻滞持续时间:MD 81.94分钟(P < .001),右美托咪定组较单纯局部麻醉药组延长。
- 眼内压:MD -2.6 mm Hg(P < .001),右美托咪定组较单纯局部麻醉药组降低。
- 补充注射需求:RR 0.44(P = .007),右美托咪定组较单纯局部麻醉药组减少。
- 首次镇痛需求时间:MD 97.15分钟(P < .001),右美托咪定组较单纯局部麻醉药组延长。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the role of dexmedetomidine as an adjuvant to local anesthetics (LA) in enhancing the duration and quality of peribulbar blocks for ophthalmic surgeries. DESIGN: Systematic review with meta-analysis and trial sequential analysis. METHODS: We systematically searched MEDLINE, Embase, and Cochrane for randomized controlled trials involving adult patients undergoing ophthalmic surgery under peribulbar block, comparing LA alone vs LA + dexmedetomidine. Risk ratios (RR) and mean differences (MD) with 95% confidence intervals were computed using a random-effects model. Sensitivity and trial-sequential analyses were performed to assess inconsistencies and weight type I and II errors, and estimate the required information size of the samples for all end points. RESULTS: Sixteen randomized controlled trials (1220 patients) were included. Compared with LA alone, dexmedetomidine was associated with prolonged (1) motor block duration (MD: 65.01 minutes, P < .001), (2) sensory block duration (MD: 81.94 minutes, P < .001), (3) reduced intraocular pressure (MD: -2.6 mm Hg, P < .001), and (4) decreased need for supplemental injections (RR: 0.44, P = .007). In addition, dexmedetomidine showed (5) longer time to analgesic request (MD: 97.15 minutes, P < .001) and (6) increased surgeon satisfaction (RR: 1.52, P = .01). Sensitivity analyses and trial-sequential analyses were consistent across all end points, and the required information size was achieved for most end points, indicating that pooled analyses were reliable and sample sizes were sufficient. CONCLUSIONS: Compared with LA alone, dexmedetomidine significantly prolonged sensory and motor block duration and the time to the first analgesic request; moreover, it decreased intraocular pressure and the need for supplemental injections, while increasing surgeon satisfaction.
引用
- Pereira EMM, Viana P, da Silva RAM, et al. Efficacy of Dexmedetomidine as an Adjuvant to Local Anesthetics in Peribulbar Block: A Meta-analysis With Trial-Sequential Analysis. Am J Ophthalmol. 2024. PMID: 39033834. doi:10.1016/j.ajo.2024.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。